Codes / ICD10CM / T50.2X4A

T50.2X4A Poisoning by carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, undetermined, initial encounter

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Poisoning by carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, undetermined, initial encounter

Summary

This condition involves harmful effects resulting from exposure to carbonic-anhydrase inhibitors, benzothiadiazides, or other diuretics, where the cause is undetermined. It includes poisoning or adverse reactions, with the initial encounter indicating the first episode of care. The clinical presentation may disrupt electrolyte balance and fluid regulation, varying by agent, dose, and patient factors.

Causes

Exposure may result from accidental or intentional ingestion, therapeutic errors, or interactions with other drugs. The cause is unspecified or unknown, often due to limited information at the time of initial assessment. This may include unreported ingestion, unclear circumstances, or lack of patient history.

Risk Factors

  • Concurrent use of medications altering electrolyte levels (e.g., other diuretics)
  • Renal impairment affecting drug clearance
  • Elderly patients or those with impaired drug metabolism
  • Non-adherence to prescribed regimens
  • Underlying conditions requiring diuretic therapy (e.g., hypertension, heart failure)

Symptoms

  • Electrolyte imbalances (e.g., hypokalemia, hyponatremia)
  • Dehydration or fluid overload
  • Gastrointestinal disturbances (nausea, vomiting)
  • Dizziness, confusion, or altered mental status
  • Cardiovascular instability (e.g., hypotension, arrhythmias)
  • Muscle weakness or cramping

Diagnosis

Diagnosis requires a thorough history, physical examination, and laboratory testing to assess electrolyte levels, renal function, and drug levels. Clinical correlation with exposure history is essential, as the cause is undetermined. Imaging or other tests may be used to rule out alternative causes.

Treatment Options

Treatment focuses on stabilizing the patient, correcting electrolyte imbalances, and managing symptoms. This may include fluid resuscitation, electrolyte replacement, and supportive care. Specific antidotes are not available for most diuretics, so management is symptomatic.

Prognosis and Follow-Up

Prognosis depends on the severity of exposure, patient factors, and timely intervention. Most cases resolve with appropriate treatment, but complications may occur with severe imbalances. Follow-up includes monitoring electrolyte levels and renal function to ensure recovery.

Complications

  • Severe electrolyte imbalances (e.g., life-threatening hypokalemia)
  • Acute kidney injury
  • Cardiovascular instability (e.g., arrhythmias, hypotension)
  • Neurological effects (e.g., seizures, coma)

Lifestyle & Prevention

  • Proper medication storage to prevent accidental ingestion
  • Clear communication with patients about dosing and side effects
  • Regular monitoring of electrolyte levels in at-risk patients
  • Avoiding concurrent use of multiple diuretics without supervision

When to Seek Professional Help

Seek immediate medical attention if symptoms of poisoning occur, such as severe nausea, vomiting, dizziness, or altered mental status. Prompt evaluation is critical to prevent complications.

Tips for Medical Coders

Document the undetermined nature of the poisoning and the initial encounter clearly. Include details about the clinical presentation, diagnostic findings, and treatment provided. Ensure the code T50.2X4A is used only for the initial encounter of undetermined poisoning by the specified agents.

Medical Policies and Guidelines

Related policies from health plans

Book a walkthrough

T50.2X4A policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.